Former FDA chief Gottlieb surprised Trump would ‘need’ hydroxychloroquine

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb responded Tuesday to President Trump’s claim that he has been taking the antimalarial drug hydroxychloroquine as a prophylactic against the coronavirus, saying he was surprised the president would “need” to take the drug.”My belief would be that he’s at very low risk of contracting COVID,” Gottlieb told CNBC, noting that Trump and everyone who comes into contact with him is…